End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 USD | +15.70% | +94.39% | -95.36% |
May. 14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 18.74M |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | 1.3 x |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | 1.53 x |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | 102 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.33% |
Latest transcript on Acorda Therapeutics, Inc.
1 day | +15.70% | ||
1 week | +94.39% | ||
1 month | +59.09% | ||
3 months | -94.96% | ||
6 months | -92.86% | ||
Current year | -95.36% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 0.7 | +15.70% | 16,122 |
24-05-17 | 0.605 | +18.63% | 5,839 |
24-05-16 | 0.51 | -20.31% | 538 |
24-05-15 | 0.64 | +68.42% | 31,214 |
24-05-14 | 0.38 | +5.53% | 26,520 |
End-of-day quote OTC Markets, May 19, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-95.36% | 869K | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.44% | 21.6B | |
-12.38% | 22.31B | |
-6.54% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- ACOR.Q Stock